STK33 and pancreatic neoplasm: Considering the well-established oncogenic functions of MACC1-AS1/STK33 in the previous findings, the present study attempted to unravel the upstream mechanism through which MACC1-AS1/STK33 contributes to gemcitabine resistance in pancreatic cancer cells.